Show simple item record

dc.contributor.authorPujol, J
dc.contributor.authorPirker, R
dc.contributor.authorLynch, T
dc.contributor.authorButts, C
dc.contributor.authorRosell, R
dc.contributor.authorShepherd, F
dc.contributor.authorVansteenkiste, J
dc.contributor.authorO'Byrne, K
dc.contributor.authorde Blas, B
dc.contributor.authorHeighway, J
dc.contributor.authorvon Heydebreck, A
dc.contributor.authorThatcher, Nick
dc.date.accessioned2014-02-10T14:20:14Z
dc.date.available2014-02-10T14:20:14Z
dc.date.issued2014-02
dc.identifier.citationMeta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer. 2014, 83 (2):211-8 Lung Canceren
dc.identifier.issn1872-8332
dc.identifier.pmid24332319
dc.identifier.doi10.1016/j.lungcan.2013.11.006
dc.identifier.urihttp://hdl.handle.net/10541/312419
dc.description.abstractFour randomized phase II/III trials investigated the addition of cetuximab to platinum-based, first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). A meta-analysis was performed to examine the benefit/risk ratio for the addition of cetuximab to chemotherapy.
dc.language.isoenen
dc.rightsArchived with thanks to Lung cancer (Amsterdam, Netherlands)en
dc.titleMeta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer.en
dc.typeArticleen
dc.contributor.departmentCentre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, Franceen
dc.identifier.journalLung Canceren
html.description.abstractFour randomized phase II/III trials investigated the addition of cetuximab to platinum-based, first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). A meta-analysis was performed to examine the benefit/risk ratio for the addition of cetuximab to chemotherapy.


Files in this item

This item appears in the following Collection(s)

Show simple item record